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Objective/purpose
The airway epithelium serves as a physical defense bar-
rier to the external environment for the underlying tis-
sue and suffers frequent injury. The response to injury
is inflammation followed by debris clearance and repair.
Although IL-13 is known to be a key cytokine in med-
iating inflammatory and remodeling responses via signal
transducer and activator of transcription 6 (STAT6) and
early growth response protein 1 (Egr1), our laboratory
has demonstrated that IL-13 is critical to airway epithe-
lial repair via the release of heparin-binding epidermal
growth factor (HB-EGF) and activation of epidermal
growth factor receptor (EGFR). IL-13 signals through
two receptors, IL-13Ra1/IL-4R and IL-13Ra2. IL-13Ra2
has previously been thought to act exclusively as a
decoy receptor, however our findings show that IL-
13Ra2 can act as a signaling receptor and is involved in
mediating airway epithelial repair. Differential signaling
via IL-13Ra1o rI L - 1 3 R a2 may determine a remodeling
versus repair response to injury in airway epithelium.
Methods
IL-13Ra1a n dI L - 1 3 R a2f u n c t i o n sw e r ed i s r u p t e di n
Human Airway Epithelial (1HAEo-) cells using specific
IL-13Ra1 and IL-13Ra2 blocking antibodies and small
interfering RNAs (siRNAs). 1HAEo- cells were also
transfected with activator protein 1 (AP-1) specific and
scramble siRNA. Following specific antibody blocking or
siRNA transfection, 1HAEo- cells were either stimulated
with IL-13 (10 ng/ml) or mechanically injured. Superna-
tants and protein lysates were collected at different time
points. Expressions of phospho-STAT6, STAT6, Egr1,
and AP-1 were detected via Western blotting, while HB-
EGF release in supernatants was quantified using ELISA.
Furthermore, AP-1 activity in 1HAEo- cells after IL-13
stimulation or mechanical injury was measured using an
AP-1-luciferase assay.
Findings
IL-13 stimulation resulted in upregulation of phospho-
STAT6, Egr1 and AP-1 expression. AP-1 expression
correlated with activity as determined by AP-1 luciferase
assay. Following mechanical injury, the expression of
phospho-STAT6 and Egr1 was inhibited when IL-13Ra1
function was disrupted, while induction of AP-1 expres-
sion is unchanged. In contrast, when IL-13Ra2 function
was disrupted, HB-EGF and AP-1 expression was inhib-
ited while STAT6/Egr1 signaling remains intact. Gene
silencing of AP-1 had no effect on phospho-STAT6
expression in response to injury, however HB-EGF
expression was significantly inhibited compared to
scramble siRNA treated cells.
Deliverables
Our data indicates that IL-13 mediates repair of airway
epithelial cells via IL-13Ra2 and AP-1, while remodeling
responses downstream of STAT-6 and EGR-1 are sig-
naled via IL-13 Ra1.
Relevance
Strategies directed towards augmentation of the IL-
13Ra2/AP-1 pathway may lead to novel therapies which
target the dysfunctional repair phenotype in asthmatic
epithelium without adverse effects on airway
remodeling.
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